New piperidinylamino-thieno(2,3-d) pyrimidine compounds

Details for Australian Patent Application No. 2004227913 (hide)

International Classifications

Event Publications

17 November 2005 PCT application entered the National Phase

PCT publication WO2004/089312 Priority application(s): WO2004/089312

14 December 2006 Assignment before Grant

Predix Pharmaceuticals Holding, Inc The application has been assigned to Epix Delaware, Inc.

1 February 2007 Change of Name(s) of Applicant(s), Section 104

Epix Delaware, Inc. The name of the applicant has been changed to EPIX Delaware, Inc.

2 December 2010 Application Accepted

Published as AU-B-2004227913

31 March 2011 Standard Patent Sealed

21 April 2011 Assignment Registered

EPIX Delaware, Inc. The patent has been assigned to Trovis Pharmaceuticals, LLC

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.